Found 9 matching trials
CD4 CAR+ ZFN-modified T Cells in HIV Therapy
PHASE1This research study is being carried out to study a new way to possibly tre...
Status
Active Not Recruiting
Location
University of Pennsylvania
Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Subjects
PHASE1This research study is being carried out to study a new way to possibly tre...
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
PHASE1This research study is being carried out to study a new way to possibly tre...
Location
UCLA Center for AIDS Research and Education
Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV
PHASE1This research study is being carried out to study a new way to possibly tre...
Location
Jacobi Medical Cener
CCR5-modified CD4+ T Cells for HIV Infection
PHASE1A Comparative Study of Autologous CD4+ T Cells Genetically Modified at the ...
Location
University of Cincinnati
Long-term Follow-up of HIV Subjects Exposed to SB-728-T or SB-728mR-T
N/ALong-term follow-up of HIV-infected subjects who received SB-728-T or SB-72...
Location
Quest Clinical Research
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
PHASE1The purpose of the study is to evaluate the safety, tolerability and effect...
A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients
PHASE1This is a triple cohort, open-label pilot study of the safety and antiviral...
Location
University of Pennsylvania
Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART
PHASE1The purpose of this study is to evaluate the safety and tolerability of rep...
Location
Multiple Locations